Professor Risteárd Ó Laoide:

At the national cancer control programme, we want the patients to get the best drugs and care we can provide in Ireland. The process in place has been agreed by a lot of the stakeholders involved. That process was then reviewed by Mazars, an external agency. It came up with some issues around it concerning tracking and transparency.